The largest database of trusted experimental protocols

29 protocols using stat3

1

Regulation of ILC3 cell signaling pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted intestinal ILC3 cells were starved for 3 hours in RPMI at 37°C in order to ensure ILC3 viability. Retfl or RetΔ were analysed directly ex vivo. To test ERK, AKT, p38-MAPK (Cell Signaling Technology) and STAT3 (BD Pharmigen) upon GFL stimulation WT ILC3 were activated with 500ng/mL (each GFL) and co-receptors (rrGFR-α1, rmGFR-α2, rrGFR-α3 and rrGNDF from R&D Systems; rhNRTN and rhARTN from PeproTech) for 10 and 30min. When referring to the use of ‘GFL’, we have employed GDNF, NRTN, ARTN and their specific co-receptors in combination. For inhibition experiments cells were incubated 1h at 37°C before GFL stimulation, to test ERK, AKT, p38/MAPK and STAT3 phosphorylation, or during overnight stimulation with GFLs, to determine Il22 expression levels. Inhibitors were purchased from Sigma-Aldrich: p38 MAPK/ERK-AKT - LY294002 (LY); ERK - PD98059 (PD); AKT - AKT Inhibitor VIII (VIII); p38 MAPK - SB 202190 (SB); and pSTAT3 – S3I-201 (S3I).
+ Open protocol
+ Expand
2

Regulation of ILC3 cell signaling pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted intestinal ILC3 cells were starved for 3 hours in RPMI at 37°C in order to ensure ILC3 viability. Retfl or RetΔ were analysed directly ex vivo. To test ERK, AKT, p38-MAPK (Cell Signaling Technology) and STAT3 (BD Pharmigen) upon GFL stimulation WT ILC3 were activated with 500ng/mL (each GFL) and co-receptors (rrGFR-α1, rmGFR-α2, rrGFR-α3 and rrGNDF from R&D Systems; rhNRTN and rhARTN from PeproTech) for 10 and 30min. When referring to the use of ‘GFL’, we have employed GDNF, NRTN, ARTN and their specific co-receptors in combination. For inhibition experiments cells were incubated 1h at 37°C before GFL stimulation, to test ERK, AKT, p38/MAPK and STAT3 phosphorylation, or during overnight stimulation with GFLs, to determine Il22 expression levels. Inhibitors were purchased from Sigma-Aldrich: p38 MAPK/ERK-AKT - LY294002 (LY); ERK - PD98059 (PD); AKT - AKT Inhibitor VIII (VIII); p38 MAPK - SB 202190 (SB); and pSTAT3 – S3I-201 (S3I).
+ Open protocol
+ Expand
3

Recombinant Interferon Biological Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biological activity of recombinant human interferon (IFNcon1, InterMune) is expressed in terms of international reference units/ml using the human NIH reference standard [35 (link)]. Antibodies against the following proteins were used: STAT1, STAT2, p-STAT1, p-STAT2, phospho-p65 and actin (Santa Cruz Biotechnology); STAT3 (BD Transduction Laboratories); pTyr-STAT3, (Abcam) and ATM (Cell Signaling). MT330 (UTHSC Department of Neurosurgery) and SJG2 (St. Jude Children's Research Hospital) GBM cell lines were grown in DMEM containing 10% fetal bovine serum (Atlanta Biologics) supplemented with penicillin (100 IU/ml) and streptomycin (100 μg/ml) at 37°C with 5% CO2.
+ Open protocol
+ Expand
4

Quantifying Interferon Activity Using Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biological activity of recombinant human interferon (IFNcon1, InterMune) was expressed in terms of international reference units/ml using the human NIH reference standard [47 (link)]. Antibodies against the following proteins were used: STAT1, STAT2, PTEN, IVNS1ABP, PI3KCA, EGFR, c-Myc, NMI, PD-L1 and actin (Santa Cruz Biotechnology); STAT3 (BD Transduction Laboratories); PDCD4, (Abcam) and FBXO11 (Novus Biologicals). MT330 (UTHSC Department of Neurosurgery), and SJG2 (St. Jude Children's Research Hospital) cell lines were grown in DMEM containing 10% Fetal Bovine serum (Atlanta Biologics) supplemented with penicillin (100 IU/ml) and streptomycin (100 mg/ml) at 37 °C with 5% CO2.
+ Open protocol
+ Expand
5

Antibody-based Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to c-Myc (sc-7274), cyclin D1 (sc-753), ErbB-3 (sc-285), Lyn A/B (sc-764), Fyn (sc-16), Src2 (sc-18), VEGF-A (sc-53462), E2A.E12 (sc-349), and ZEB1(sc-10572) (Santa Cruz Biotechnology), p27Kip1 (BD-Pharmingen 554069), ALDH1 (BD, 661194), Stat3 (BD-Transduction Laboratories, S21320), Twist1/2 (Gene Tex, GTX127310), pY705-Stat3 (Cell Signaling Technology, #9131), Snail-1 (Cell Signaling Technology, LF062), CK5 (ABCAM, ab52635), pY418-Src (Invitrogen, 44660G), GAPDH (MAB374) and MMP9 (AB19016) (Millipore), PARP (Biomol, SA-249 clone C-2_10), β-actin (A5441), TAZ (HPA007415), and hydrocortisone were from Sigma-Aldrich, and CD44 (clone HP 2/9) was a gitf from Dr. F. Sanchez-Madrid (University Hospital La Princesa, UAM) [17 (link)], MatrigelTM (Corning). Secondary horseradish peroxidase-conjugated antibodies, and B27 (Life Technologies). EGF, and bFGF (PeproTech EC Ltd). Fetal Calf Serum (FCS), Acrylamide/Bisacrylamide, SDS and ammonium persulfate (Bio-Rad Laboratories). ECL (GE Healthcare Biosciences). BCA protein assay (Thermo Scientific).
+ Open protocol
+ Expand
6

Protein Signaling in Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNU-16 parental and resistant cells were seeded in six-well plates at a density of 0.5 × 106 cells per milliliter in an inhibitor-free medium. After 24 h, cells were lysed and the level of proteins was examined by Western blotting according to the protocols provided by the antibody suppliers. The antibodies against MET, EGFR, HER2, extracellular-signal-regulated kinase (ERK), phosphorylated AKT, phosphorylated EGFR, phosphorylated ERK (pERK), phosphorylated FGFR, phosphorylated FGFR substrate, and phosphorylated signal transducer and activator of transcription (STAT3) were purchased from Cell Signaling Technology, β-tubulin and AKT were from Millipore, E-cadherin, STAT3, and β-catenin were from BD Biosciences, FGFR2 was from Abnova, and vimentin was from Calbiochem. All experiments were performed at least twice.
+ Open protocol
+ Expand
7

Western Blot Analysis of XBP1 and Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For XBP1 blotting, nuclei were extracted using CelLytic NuCLEAR Extraction Kit (Sigma-Aldrich). Protein from cells or nuclei were dissolved in 1x SDS loading buffer and separated on SDS-PAGE gels as described previously (Ameri et al., 2014 (link)). Subsequently, proteins were electroblotted onto nitrocellulose or PVDF membranes (Bio-Rad Laboratories, Hercules, CA), probed with primary and secondary antibodies, and detected using the enhanced chemiluminescence (ECL) system (Pierce, Rockford, IL). The primary antibodies included the following: Phospho-PERK (Thr980), PERK, Phospho-NF-κB RelA (Ser 468), NF-κB, IκBα, JAK1 and Phospho-STAT3 (Tyr705) from Cell Signaling Technology (Beverly, MA); phospho-JAK1 (Thy1022/Tyr1023) from EMD Millipore (Billerica, MA); STAT3 from BD biosciences (San Jose, CA); XBP1 from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal anti-α-Tubulin (Sigma-Aldrich) and rabbit monoclonal anti-Lamin B1 (Cell Signaling Technology) were used as loading controls. Densitometry analysis was conducted using ImageJ software.
+ Open protocol
+ Expand
8

Oxaliplatin and CTSS Inhibitor Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oxaliplatin was purchased from Sanofi Pharmaceutical Company (NY, USA). The procedure for synthesizing the CTSS inhibitor RJW-58 was described previously 14 (link). The following primary antibodies were purchased: Cathepsin S (Thermo Fisher catalog: #PA5-81369), EBF (Santa Cruz, #sc-137065), ATF-3 (Biossua, #BS-0519R), α-tubulin (Sigma, MO, USA), IRF-1 (Bio-Rad, #VPA00801), CBP (GeneTex, #GTX101249), Iba1 (Abcam, #ab-5076), NeuN (Novus, #NBP2-10491), IL-10 (Abcam, #ab189392), STIM1 (Cell signaling (D88E10), #5668S), CD11b (Abcam, #ab52478), CD45 (BD Biosciences, #553079), STAT3 (BD, #50402), P-STAT3 (Cell signaling, #9145S), NFκB (Cell signaling, #4727S), OR5B3 (Abcam, #ab186624), OR5M3 (LSBio, #LS-C200406), and β-actin (GeneTex, #GTX109639). Horseradish-peroxidase-conjugated secondary antibodies were purchased from GeneTex (#GTX213110, #GTX213111, #GTX224125, and #GTX232040).
+ Open protocol
+ Expand
9

Western Blot Analysis of GIC Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts (50 μg) were prepared from GICs in urea-based lysis buffer as previously described [28 (link),29 (link)], separated by SDS-PAGE, transferred to polyvinylidene difluoride membranes (Millipore, Burlington, MA), and immunoblotted with the following antibodies: BRG1 and BRM (Proteintech, Rosemont, IL), TXNIP (Abcam, Cambridge, MA), STAT3 (BD Biosciences, San Jose, CA), pY705-STAT3 and GFAP (Abcam), CDK1, CDK2, Rb, Rb 107, Rb 110 (Cell Signaling, Danvers, MA), and Actin (Santa Cruz, Dallas, TX). Following addition of IRDye800CW goat anti-mouse IgG or IRDye680 goat anti-rabbit IgG, blots were visualized on an Odyssey infrared imaging system (LICOR Biosciences, Lincoln, NE).
+ Open protocol
+ Expand
10

Western Blot Analysis of STAT Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
GICs were lysed at 4°C for 30 min in RIPA buffer (Sigma Aldrich, St Louis, MO) supplemented with protease inhibitor (Sigma Aldrich, St Louis, MO) and phosphatase inhibitor (BioTools, Jupiter, FL), followed by centrifugation (10,000xg for 10 min). Protein extracts (50μg) were separated by SDS-PAGE, transferred to polyvinylidene difluoride membranes (Millipore, Burlington, MA), and immunoblotted with the following antibodies: STAT3 and pS727-STAT3 (BD Biosciences, San Jose, CA), pY705-STAT3 (Abcam, Cambridge, A), STAT1 and STAT5 (Cell Signaling, Danvers, MA), and Actin (Santa Cruz Biotechnology, Dallas, TX). Following addition of IRDye800CW goat anti-mouse IgG or IRDye680 goat anti-rabbit IgG, blots were visualized on an Odyssey infrared imaging system (LICOR Biosciences, Lincoln, NE).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!